SOX7 and central nervous system cancer: One study demonstrated SOX7 to be downregulated in human glioma, allowing cancer development through upregulated Wnt/β-catenin signaling [101], whereas another study demonstrated that overexpression of SOX7 in high-grade glioma (HGG) promoted cancer development by promoting tumor growth via vessel abnormalization [102].